公司資料
Endonovo Therapeutics 股價、新聞與催化劑
- 股票代碼:
- ENDV
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States and traded publicly
股票表現
0.00 USD (0.00%)
收盤價
最後更新: 2026年8月17日
—
市值
股價為何變動
As of Aug 17, 2026, ENDV was little changed and closed at $0.0001. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Endonovo Therapeutics was a medical technology company focused on bioelectronic or regenerative applications for inflammation and pain. Its story centered on device-based therapy rather than classic pharmaceuticals.
所在地與產業分類
Endonovo was headquartered in the United States and traded publicly. It sat in medical technology and bioelectronic medicine.
商業模式特徵
The company depended on product development, commercialization, and the ability to show clinical utility. Investors historically watched device progress and strategic changes.
生技產業定位
Endonovo occupies a historical bioelectronic-device niche. It is outside biotech therapeutics and more closely aligned with device-driven care.
未來催化劑
- Endonovo is a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update rather than a live product milestone. The market is focused on residual value.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。